|
Welcome to your August newsletter from the EGFR Patient Gateway: your place for the latest information about EGFR-positive lung cancer.
Research NewsThroughout the year, LUNGevity brings you news from the biggest oncology conferences so that you can stay current on the progress and breakthroughs in EGFR+ lung cancer research and treatment. The 2026 American Society of Clinical Oncology (ASCO) meeting offered tremendous hope and progress for treating many types of cancer, including EGFR+ non-small cell lung cancer (NSCLC). Developing a TKI for non-classical EGFR
mutations
Scientists aim to improve treatment options for patients with both “classical” and “non-classical” EGFR mutations with the development of silevertinib, a fourth-generation EGFR-targeted TKI. The results of a phase 2 study testing this treatment reported promising results at the ASCO meeting.
Building a new first-line option for NSCLC with EGFR exon 20 insertions
NSCLC with EGFR exon 20 insertions have historically been harder to treat with standard EGFR-targeted medicines, leaving chemotherapy as a common initial treatment. Sunvozertinib, a TKI, has received accelerated approval by the FDA for treating patients with advanced NSCLC with EGFR exon 20 insertions after initial treatment. Researchers at the ASCO meeting presented promising results from a study looking at the effects of sunvozertinib as a first-line treatment.
The annual meeting of the American Association for Cancer Research (AACR) conference offered opportunities to recognize the incredible patient advocacy in the EGFR+ lung cancer community while learning about research progress.
Celebrating Advocacy and Progress
In addition to the impactful lung cancer science presented at the meeting, Jill Feldman, co-founder of the EGFR Resisters, was honored with the 2026 AACR Distinguished Patient Advocacy and Engagement Award.
News You Can Use Comfort Through Hair Loss
Hair loss can bring tough decisions about shaving and what to wear. In this expert talk, you can learn what to expect with chemotherapy treatment plus practical tips for gentle scalp care. Don’t miss the chance to explore wig alternatives and an easy “t-shirt technique” for making a comfortable head covering. It’s packed with ideas you can use right away.
Neuropathy and Lung Cancer
Tingling in the hands? Feet feeling numb? These are often signs of peripheral neuropathy. Watch our pre-recorded session with a nurse practitioner as she clarifies the different types of neuropathy, the causes and symptoms of neuropathy, and treatment options to consider.
Get Connected Advocate for Change This November
Lung Cancer Awareness Month is in November, and LUNGevity is ready to amplify the voices of our community to bring awareness and education about lung cancer. The best part? You can do it your way: in your home with a special flag display or by participating in a Breathe Deep event.
Listen to the Latest Podcast on Lung Cancer
“Lung Cancer Voices of Hope” is a new podcast from LUNGevity Foundation featuring hosts Ann Steagall, RN, BSN, and Misty Shields, MD, PhD. Each episode brings together someone living with lung cancer and a leading expert to offer clinical insights and patient perspectives. If you or a loved one is living with lung cancer, this podcast is here to help you make more informed decisions and feel less alone.
Join Us for the EGFR Virtual Meetup
This is an easy way to build your community. On the first Wednesday of each month, you can connect with others who understand what it’s like to live with EGFR-positive lung cancer. The next EGFR Meetup is happening on September 2, 2026, at 12 pm ET. Register for free to get a confirmation email with details about how to join the virtual meeting. New attendees are always welcome and encouraged to join! Can’t make it? Don’t worry, there’s a full list of virtual meetups to fit your schedule.
… and there is always so much more to explore on the EGFR Patient Gateway. If you were forwarded this email and you’d like to subscribe to this newsletter, you can sign up here. If you need further assistance along your lung cancer journey, please email us at support@lungevity.org. Our team is always here to assist you.
|